SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1445This from Yahoo thread. Answer to the question. cooperation?? The two drugs arePL Wilson-12/4/2000
1444Sorry for the dumb question, but what is the connection to gnta? Thanks.tommtn-12/4/2000
1443And closer to home: ohsu.edu Regards, CraigCraig Lacy-12/4/2000
1442Multiple Myeloma Reported Responsive to Bcl-2 Antisense Treatment BERKELEY HEIGbob zagorin-12/4/2000
1441GNTA to be traded on The Chicago Board Options Exchange. Friday December 1, 5:14PL Wilson-12/3/2000
1440Decision Resources Study Evaluates the Potential for Genomics-BasedTherapy to Trbob zagorin-11/27/2000
1439GENTA INCORPORATED /DE/ has filed a Form S-3 (Registration Statement) with the Ubob zagorin-11/20/2000
1438Another Presentation:@THE AMERICAN SOCIETY OF HEMATOLOGY (513] PHASE I TRIAL OF PL Wilson-11/18/2000
1437THE AMERICAN SOCIETY OF HEMATOLOGY 42ND ANNUAL MEETING AND EXPOSITION December PL Wilson-11/18/2000
1436Genta's Lead Antisense Drug Reported Active in Malignant Melanoma New Data obob zagorin-11/17/2000
1435This from Yahoo thread:The Lancet issue of Nov 18.(Thanks to unclebake.) The pePL Wilson-11/17/2000
1434GENTA INCORPORATED /DE/ has filed a Form 10-Q (Quarterly Report) with the Unitedbob zagorin-11/14/2000
1433Monday November 13, 1:12 pm Eastern Time Investigators Report Activity for Genabob zagorin-11/13/2000
1432Investigators Report Activity for Genasense(TM), Genta's Lead Antisense CompPL Wilson-11/13/2000
1431Genta Raises $28 Million in Equity Placement BERKELEY HEIGHTS, N.J., Nov 13 /PRbob zagorin-11/13/2000
1430Listen to this video on yahoo:(Thu Nov 9 GNTA [video] Forget the Dow for Now, ThPL Wilson-11/10/2000
1429SAN DIEGO--(BW HealthWire)--Nov. 6, 2000--Privately-held Structural BioinformatiJim Oravetz-11/6/2000
1428Genta Incorporated Announces Third Quarter 2000 Results BERKELEY HEIGHTS, N.J.,bob zagorin-11/3/2000
1427Decision Resources Study Evaluates the Potential for Genomics-Based Therapyto Trbob zagorin-10/31/2000
1426Genta's CEO Outlines Company's Program in Hematology at National Leukemibob zagorin-10/16/2000
1425Genta Announces Appointment of Distinguished Scientists to Its Advisory Board Bbob zagorin-10/10/2000
1424Genta Raises $14.6 Million In Private Placement BERKELEY HEIGHTS, N.J., Oct. 2 bob zagorin-10/2/2000
1423Genta Announces Licensing Deal for Antisense Technology To Oasis Biosciences BEbob zagorin-9/28/2000
1422Genta's CEO Presents Updated Clinical Trials Results And Proposed New Clinicbob zagorin-9/19/2000
1421CytoGenix's `Universal' Expression System Encompasses Multiple TherapeutPL Wilson-9/18/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News